Source link : https://www.newshealth.biz/health-news/canakinumab-effective-as-steroid-free-first-line-sjia-drug/
VIENNA — The interleukin 1 receptor antagonist (IL-1RA) canakinumab provided control of systemic juvenile idiopathic arthritis (sJIA) without the use of glucocorticoids for up to a year in most study participants after 3 monthly injections. In this study of 20 patients with newly diagnosed sJIA treated off glucocorticoids, fever was controlled after a single injection […]
Author : News Health
Publish date : 2024-06-26 09:39:56
Copyright for syndicated content belongs to the linked Source.
Categories